Drug search by name

Dexlansoprazole Capsules and Liver disease

Result of checking the interaction of drug Dexlansoprazole Capsules and disease Liver disease for safety when used together.

Check result:

Dexlansoprazole Capsules <> Liver disease

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Dexlansoprazole is primarily metabolized by the liver. No dosage adjustment is necessary for patients with mild hepatic impairment (Child Pugh Class A). A dose of 30 mg should be considered for patients with moderate hepatic impairment (Child Pugh Class B). No studies have been conducted in patients with severe hepatic impairment (Child Pugh Class C).

Dexlansoprazole Capsules

Generic Name: dexlansoprazole

Brand Name: Dexilant, Kapidex

Synonyms: Dexlansoprazole

What is Dexlansoprazole Capsules?